Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -722 | -2,052 | -4,355 | -3,560 | -2,289 |
| Depreciation Amortization | 208 | 973 | 958 | 768 | 364 |
| Accounts receivable | 12 | 69 | 69 | 6 | 52 |
| Accounts payable and accrued liabilities | 297 | 1,475 | 1,265 | 944 | 584 |
| Other Working Capital | 359 | 1,752 | 1,464 | 1,032 | 669 |
| Other Operating Activity | -292 | -274 | -127 | 323 | 242 |
| Operating Cash Flow | $-138 | $1,941 | $-726 | $-487 | $-377 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -3,143 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-3,143 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 111 | N/A | 350 | 0 | N/A |
| Common Stock Issued | N/A | N/A | 120 | 100 | 100 |
| Other Financing Activity | 0 | 908 | 50 | 70 | 70 |
| Financing Cash Flow | $111 | $908 | $520 | $170 | $170 |
| Beginning Cash Position | 344 | 344 | 344 | 344 | 344 |
| End Cash Position | 50 | 50 | 138 | 27 | 137 |
| Net Cash Flow | $-27 | $-294 | $-206 | $-317 | $-207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138 | 1,941 | -726 | -487 | -377 |
| Free Cash Flow | -138 | 1,941 | -726 | -487 | -377 |